Prime Medicine announces common stock offering, no amount given

Prime Medicine (PRME) announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares of common stock in the proposed offering are to be sold by Prime Medicine. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. TD Cowen and BMO Capital Markets are acting as joint book-running managers for the proposed offering.